R&D Sponsored From Alzheimer’s disease research to the real-world setting:... In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space.
R&D Sponsored A data-driven guide to small molecule drug discovery and dev... A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.
Digital Sponsored Expert Directed Applied Intelligence: Redefining AI in Life ... In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.
Sales & Marketing Sponsored The strategic imperative of Integrated Evidence Generation P... Integrated Evidence Generation Planning (IEGP) is recognised as a strategic necessity for biopharmaceutical organisations.
Digital Sponsored Data managers and CRAs warn of rising data quality risks due... A new industry report uncovers the scope of a long-ignored problem in clinical trial operations.
R&D Sponsored A New Framework to Engineer Breakthrough Value for Medicines A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.
News Zymeworks cuts deal to buy Theravance for $929m in cash Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.